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Dear Editor,
Honest errors, sloppy practices or true frauds: there can
be several causes of inconsistences and problematic data
in a scientiﬁc paper. However, whatever the actual out-
come of an investigation into a case of alleged data
manipulation, there are certain ﬁrm principles that always
hold true, and certain errors that must be avoided.
In the most recent, high-proﬁle case of allegedly
manipulated images in scientiﬁc papers, we learnt from
the principal investigator that irrespective of the investi-
gation outcomes and of any actual manipulations:
“I remain conﬁdent about the validity and strength of
the scientiﬁc conclusions made in those publications.”1
Nearly all scientists accused of data manipulation come
up with similar words; more worryingly, such a view
recently seems also to be shared by those appointed to
judge cases of potential misconduct.
While it might be true that the scientiﬁc conclusions of
some research papers under investigation will eventually
appear supported by overwhelming scientiﬁc evidence, we
take this occasion to recall a few concepts that seem to be
at stake every time the focus shifts from investigating the
evidence for data manipulation to assessing the theories
those data were intended to support.
Pretending that erroneous or fraudulent data manip-
ulation is more acceptable if, retrospectively, it does not
compromise the validity of the main conclusions of a
scientiﬁc work, involves accepting that sloppy or decep-
tive practices are forgivable or less serious, if the
hypothesis one intends to support eventually proves right.
This is equivalent to accepting a scientist’s educated
guess, instead of relying on actual experimental data.
Such an attitude is radically opposed to the scientiﬁc
method and the ethics of scientiﬁc knowledge according
to Jacques Monod. The ethical commitment of a scientist
is to produce and communicate objective facts. Double
standards cannot be accepted, neither by those who
allegedly fabricated, falsiﬁed or duplicated experimental
data, nor by those assessing the seriousness of a suspected
manipulative behaviour, for the following reasons:
1. It undermines the trust in the data produced by
researchers, and so the trust in science itself.
2. It brings back science to the speculative approach of
the premodern world, well before the experimental
method transformed the investigation of the natural
world; back then theories were formulated mainly
based on a purely deductive approach, from
arbitrarily selected ﬁrst principles.
3. It shifts the examination of a potential misconduct
case from the assessment of the actual behaviour
and responsibility of the people involved, to the
validity of the theory they happened to disclose to
the scientiﬁc community.
4. It confers an unfair advantage onto those who, in the
current, prevalent publish-or-perish competition,
have few if any actual experimental evidence, but ﬁll
the gaps with improperly duplicated or
manipulated data.
The duplication or the alteration of data in a published
paper might be due to honest error, and a research group,
including the principal investigator, might on occasion
have been fooled by a single, dishonest or sloppy
researcher. But once a duplication, a falsiﬁcation or a
fabrication is discovered in a published paper, one cannot
appeal to the validity of the scientiﬁc conclusions of a
paper to avoid or delay one of the main duties of the
researcher: which is to correct the published record. This
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must follow a thorough and honest disclosure of all the
potential problems and biases that caused the leakage of
less-than-clean data into a scientiﬁc publication, in order
to reassure peers, institutions and the public that every
reasonable system to avoid further problems is in place.
The relentless defence of duplicated, fabricated or fal-
siﬁed data is, per se, a form of serious misconduct, which
transforms even an honest error into pertinacious mis-
behaviour, and honesty must be prized at least as intelli-
gence and knowledge, to ensure that science corrects
itself.
Author details
1Biotechnology Department, Università di Verona, Strada Le Grazie 15, 37134
Verona, Italy. 2Accademia Nazionale dei Lincei, Roma, Italy. 3Sbarro Health
Research Organization, c/o Temple University, 1900 N 12th St -, 19122
Philadelphia, PA, USA. 4Department of Molecular Biotechnology and Health
Sciences, University of Torino, Via Nizza 52, 10125 Torino, Italy. 5RIKEN Center
for Integrative Medical Sciences, Yokohama, Kanagawa, Japan230-0045. 6IRCCS,
Regina Elena National Cancer Institute, Rome, Italy. 7Department of
Agricultural, Food and Forest Sciences, University of Palermo, Viale delle
Scienze, Building 4, 90128 Palermo, Italy. 8Center for Regenerative Medicine
“Stefano Ferrari,” Department of Life Sciences, University of Modena and
Reggio Emilia, 41125 Modena, Italy. 9Department of Molecular Medicine,
“Sapienza” University of Rome, Rome, Italy. 10Sidney Kimmel Comprehensive
Cancer Center, Johns Hopkins University, 401 N Broadway, Baltimore, MD
21231, USA. 11Department of Ophthalmology, Scheie Eye Institute, University
of Pennsylvania, Philadelphia, PA, USA. 12INSERM, U1048, Toulouse F-31432,
France. 13Université de Toulouse, UPS, Faculté des Sciences Pharmaceutiques,
F-31062 Toulouse, France. 14Department of Pharmacy, University of Salerno,
Fisciano I-84084, Italy
Conﬂict of interest
Enrico M. Bucci is the owner of Resis Srl, a company devoted to improving
research integrity in the scientiﬁc community; as such, he was and is involved
as expert consultant in several investigations on potential and actual
misconduct cases. He is also involved in pre-submission screening of scientiﬁc
papers to ensure data integrity. All other authors declare that they have no
conﬂict of interest.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Received: 25 November 2019 Accepted: 27 November 2019
References
1. Normile, D. Top Chinese researcher faces questions about image manipulation.
Science https://doi.org/10.1126/science.aba3212 (2019).
Bassi et al. Cell Death and Disease          (2019) 10:931 Page 2 of 2
Ofﬁcial journal of the Cell Death Differentiation Association
